Exact Mass: 399.2521788

Exact Mass Matches: 399.2521788

Found 360 metabolites which its exact mass value is equals to given mass value 399.2521788, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Spiramine A

[(1R,2R,3S,5S,7R,8R,12R,13R,18R,21R)-12-methyl-4-methylidene-14,19-dioxa-17-azaheptacyclo[10.7.2.22,5.02,7.08,18.08,21.013,17]tricosan-3-yl] acetate

C24H33NO4 (399.2409458000001)


Spiramine A is a diterpenoid. It derives from a hydride of an atisane. Spiramine A is a natural product found in Spiraea japonica with data available.

   
   

Quinacrine

N(4)-(6-Chloro-2-methoxy-9-acridinyl)-N(1),N(1)-diethyl-1,4-pentanediamine

C23H30ClN3O (399.20772800000003)


An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2. [PubChem] P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01A - Agents against amoebiasis and other protozoal diseases D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors

   

candoxatrilat

4-((2-Carboxy-3-(2-methoxyethoxy)propyl)-1-cyclopentanecarbonylamino)-1-cyclohexanecarboxylic acid

C20H33NO7 (399.22569080000005)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

(5Z)-13-Carboxytridec-5-enoylcarnitine

3-{[(5Z)-13-carboxytridec-5-enoyl]oxy}-4-(trimethylammonio)butanoic acid

C21H37NO6 (399.26207420000003)


(5Z)-13-Carboxytridec-5-enoylcarnitine is an acylcarnitine. More specifically, it is an (5Z)-tetradec-5-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (5Z)-13-Carboxytridec-5-enoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (5Z)-13-Carboxytridec-5-enoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(7Z)-Tetradec-7-enedioylcarnitine

3-[(13-carboxytridec-7-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C21H37NO6 (399.26207420000003)


(7Z)-Tetradec-7-enedioylcarnitine is an acylcarnitine. More specifically, it is an (7Z)-tetradec-7-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (7Z)-Tetradec-7-enedioylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (7Z)-Tetradec-7-enedioylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2E)-Tetradec-2-enedioylcarnitine

3-[(13-Carboxytridec-2-enoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C21H37NO6 (399.26207420000003)


(2E)-Tetradec-2-enedioylcarnitine is an acylcarnitine. More specifically, it is an (2E)-tetradec-2-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2E)-Tetradec-2-enedioylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (2E)-Tetradec-2-enedioylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(4Z)-Tetradec-4-enedioylcarnitine

3-[(13-carboxytridec-4-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C21H37NO6 (399.26207420000003)


(4Z)-Tetradec-4-enedioylcarnitine is an acylcarnitine. More specifically, it is an (4Z)-tetradec-4-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4Z)-Tetradec-4-enedioylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (4Z)-Tetradec-4-enedioylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(5E)-Tetradec-5-enedioylcarnitine

3-[(13-Carboxytridec-5-enoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C21H37NO6 (399.26207420000003)


(5E)-Tetradec-5-enedioylcarnitine is an acylcarnitine. More specifically, it is an (5E)-tetradec-5-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (5E)-Tetradec-5-enedioylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (5E)-Tetradec-5-enedioylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

N-Stearoyl Aspartic acid

2-[(1-Hydroxyoctadecylidene)amino]butanedioate

C22H41NO5 (399.29845760000006)


N-stearoyl aspartic acid, also known as N-stearoyl aspartate belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Stearic acid amide of Aspartic acid. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Stearoyl Aspartic acid is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Stearoyl Aspartic acid is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

N-Docosahexaenoyl Alanine

2-(docosa-4,7,10,13,16,19-hexaenamido)propanoic acid

C25H37NO3 (399.27732920000005)


N-docosahexaenoyl alanine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Docosahexaenoic acd amide of Alanine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Docosahexaenoyl Alanine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Docosahexaenoyl Alanine is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

N-Eicosapentaenoyl Proline

1-(icosa-5,8,11,14,17-pentaenoyl)pyrrolidine-2-carboxylic acid

C25H37NO3 (399.27732920000005)


N-eicosapentaenoyl proline belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Eicosapentaenoic acid amide of Proline. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Eicosapentaenoyl Proline is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Eicosapentaenoyl Proline is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

21-Desacetyl Deflazacort

11-hydroxy-8-(2-hydroxyacetyl)-6,9,13-trimethyl-5-oxa-7-azapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosa-6,14,17-trien-16-one

C23H29NO5 (399.20456240000004)


   

Candoxatrilat

4-{[(1-{2-carboxy-2-[(2-methoxyethoxy)methyl]ethyl}cyclopentyl)(hydroxy)methylidene]amino}cyclohexane-1-carboxylate

C20H33NO7 (399.22569080000005)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors

   

Dorsomorphin

4-(6-{4-[2-(piperidin-1-yl)ethoxy]phenyl}pyrazolo[1,5-a]pyrimidin-3-yl)pyridine

C24H25N5O (399.2059)


D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors Dorsomorphin (Compound C) is a selective and ATP-competitive AMPK inhibitor (Ki=109 nM in the absence of AMP). Dorsomorphin (BML-275) selectively inhibits BMP type I receptors ALK2, ALK3, and ALK6. Dorsomorphin can reverse autophagy activation and anti-inflammatory effect of Urolithin A (HY-100599)[1][2].

   

Epristeride

14-(tert-butylcarbamoyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-5,7-diene-5-carboxylic acid

C25H37NO3 (399.27732920000005)


   

Phenylalanyl-prolyl-arginine nitrile

2-amino-N-(1-{1-cyano-4-[(diaminomethylidene)amino]butyl}pyrrolidine-2-carbonyl)-3-phenylpropanamide

C20H29N7O2 (399.2382614)


   

1,19-Epoxydenudatine 11-acetate

1,19-Epoxydenudatine 11-acetate

C24H33NO4 (399.2409458000001)


   

Dehydrolucidusculine

1-Deoxy-1,19-epoxylucidusculine

C24H33NO4 (399.2409458000001)


   
   
   
   
   
   

Spiradine F

[(1S,2R,5S,7R,8R,12R,13S,20S,21R)-12-methyl-4-methylidene-14,19-dioxa-17-azaheptacyclo[10.7.2.2^{2,5.0^{2,7.0^{8,18.0^{8,21.0^{13,17]tricosan-20-yl] acetate

C24H33NO4 (399.2409458000001)


   

12-Epiacetyldehydronapelline

12-Epidehydronapelline 12-acetate

C24H33NO4 (399.2409458000001)


   
   
   

Sczukinine

Sczukidine 2-acetate

C23H29NO5 (399.20456240000004)


   
   

subdesculine

Anhydroepoxynapelline 12-acetate

C24H33NO4 (399.2409458000001)


   
   
   

Myriocin-12-en

Myriocin-12-en

C21H37NO6 (399.26207420000003)


[Raw Data] CBA30_Myriocin-12-en_neg_40eV_1-4_01_1594.txt [Raw Data] CBA30_Myriocin-12-en_neg_30eV_1-4_01_1593.txt [Raw Data] CBA30_Myriocin-12-en_neg_20eV_1-4_01_1592.txt [Raw Data] CBA30_Myriocin-12-en_neg_10eV_1-4_01_1579.txt [Raw Data] CBA30_Myriocin-12-en_pos_50eV_1-4_01_1564.txt [Raw Data] CBA30_Myriocin-12-en_pos_40eV_1-4_01_1563.txt [Raw Data] CBA30_Myriocin-12-en_pos_30eV_1-4_01_1562.txt [Raw Data] CBA30_Myriocin-12-en_pos_20eV_1-4_01_1561.txt [Raw Data] CBA30_Myriocin-12-en_pos_10eV_1-4_01_1547.txt

   

(3Z)-3-[[1,6-dimethyl-2-[(1E,3E)-penta-1,3-dienyl]-4a,5,6,7,8,8a-hexahydro-2H-naphthalen-1-yl]-hydroxymethylidene]-5-(1-hydroxyethyl)pyrrolidine-2,4-dione

(3Z)-3-[[1,6-dimethyl-2-[(1E,3E)-penta-1,3-dienyl]-4a,5,6,7,8,8a-hexahydro-2H-naphthalen-1-yl]-hydroxymethylidene]-5-(1-hydroxyethyl)pyrrolidine-2,4-dione

C24H33NO4 (399.2409458000001)


   
   
   
   
   

5-epi-smenospongorine|epi-smenospongiarine

5-epi-smenospongorine|epi-smenospongiarine

C25H37NO3 (399.27732920000005)


   
   

6-hydroxy-4-methoxyl-5-[(2E,6E)-(3,7,11-trimethyl-2,6,10-dodecatrien-1-yl)oxy]-2,3-dihydro-1H-isoindol-1-one|emeriphenolicin D

6-hydroxy-4-methoxyl-5-[(2E,6E)-(3,7,11-trimethyl-2,6,10-dodecatrien-1-yl)oxy]-2,3-dihydro-1H-isoindol-1-one|emeriphenolicin D

C24H33NO4 (399.2409458000001)


   

(13R)-2alpha,11alpha-dihydroxy-13-isobutyryloxyhetisane|trichodelphinine B

(13R)-2alpha,11alpha-dihydroxy-13-isobutyryloxyhetisane|trichodelphinine B

C24H33NO4 (399.2409458000001)


   
   
   

3-Deoxy-3-methylaminoxylose-beta-D-Furanose-form-Me glycoside, 2,5-dibenzyl, N-Ac|3-Deoxy-3-methylaminoxylose-Me glyoside, n-jAc, 2,5-dibenzyl

3-Deoxy-3-methylaminoxylose-beta-D-Furanose-form-Me glycoside, 2,5-dibenzyl, N-Ac|3-Deoxy-3-methylaminoxylose-Me glyoside, n-jAc, 2,5-dibenzyl

C23H29NO5 (399.20456240000004)


   

2-benzyl-3-phenyl-propionic acid-[2-(2-diethylamino-ethylsulfanyl)-ethyl ester]|2-Benzyl-3-phenyl-propionsaeure-[2-(2-diaethylamino-aethylmercapto)-aethylester]

2-benzyl-3-phenyl-propionic acid-[2-(2-diethylamino-ethylsulfanyl)-ethyl ester]|2-Benzyl-3-phenyl-propionsaeure-[2-(2-diaethylamino-aethylmercapto)-aethylester]

C24H33NO2S (399.22318780000006)


   
   

8-hydroxy-isokalihinol F

8-hydroxy-isokalihinol F

C23H33N3O3 (399.2521788)


   
   

H-Ala-Ala-Pro-Ala-Ala-OH

H-Ala-Ala-Pro-Ala-Ala-OH

C17H29N5O6 (399.2117734)


   
   
   

Mepacrine

Quinacrine Dihydrochloride Dihydrate

C23H30ClN3O (399.20772800000003)


P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01A - Agents against amoebiasis and other protozoal diseases D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent [Raw Data] CB204_Mepacrine_neg_30eV_000037.txt D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors [Raw Data] CB204_Mepacrine_neg_20eV_000037.txt [Raw Data] CB204_Mepacrine_neg_10eV_000037.txt [Raw Data] CB204_Mepacrine_pos_50eV_isCID-10eV_rep000007.txt [Raw Data] CB204_Mepacrine_pos_40eV_isCID-10eV_rep000007.txt [Raw Data] CB204_Mepacrine_pos_30eV_isCID-10eV_rep000007.txt [Raw Data] CB204_Mepacrine_pos_20eV_isCID-10eV_rep000007.txt [Raw Data] CB204_Mepacrine_pos_10eV_isCID-10eV_rep000007.txt

   

(3Z)-3-[[1,6-dimethyl-2-[(1E,3E)-penta-1,3-dienyl]-4a,5,6,7,8,8a-hexahydro-2H-naphthalen-1-yl]-hydroxymethylidene]-5-(1-hydroxyethyl)pyrrolidine-2,4-dione

NCGC00347691-02!(3Z)-3-[[1,6-dimethyl-2-[(1E,3E)-penta-1,3-dienyl]-4a,5,6,7,8,8a-hexahydro-2H-naphthalen-1-yl]-hydroxymethylidene]-5-(1-hydroxyethyl)pyrrolidine-2,4-dione

C24H33NO4 (399.2409458000001)


   
   
   
   
   

Ala Gly Pro Arg

(2S)-2-{[(2S)-1-{2-[(2S)-2-aminopropanamido]acetyl}pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C16H29N7O5 (399.22300640000003)


   

Ala Gly Arg Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C16H29N7O5 (399.22300640000003)


   

Ala Asn Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C17H29N5O6 (399.2117734)


   

Ala Asn Val Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6 (399.2117734)


   

Ala Pro Gly Arg

(2S)-2-(2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}acetamido)-5-carbamimidamidopentanoic acid

C16H29N7O5 (399.22300640000003)


   

Ala Pro Asn Val

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-3-methylbutanoic acid

C17H29N5O6 (399.2117734)


   

Ala Pro Arg Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]acetic acid

C16H29N7O5 (399.22300640000003)


   

Ala Pro Val Asn

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-3-carbamoylpropanoic acid

C17H29N5O6 (399.2117734)


   

Ala Arg Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanamido]acetyl}pyrrolidine-2-carboxylic acid

C16H29N7O5 (399.22300640000003)


   

Ala Arg Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}acetic acid

C16H29N7O5 (399.22300640000003)


   

Ala Val Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6 (399.2117734)


   

Ala Val Pro Asn

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C17H29N5O6 (399.2117734)


   

Gly Ala Pro Arg

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)propanoyl]pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanoic acid

C16H29N7O5 (399.22300640000003)


   

Gly Ala Arg Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-5-carbamimidamidopentanoyl]pyrrolidine-2-carboxylic acid

C16H29N7O5 (399.22300640000003)


   

Gly Ile Asn Pro

(2S)-1-[(2S)-2-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6 (399.2117734)


   

Gly Ile Pro Asn

(2S)-2-{[(2S)-1-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C17H29N5O6 (399.2117734)


   

Gly Lys Pro Val

(2S)-2-{[(2S)-1-[(2S)-6-amino-2-(2-aminoacetamido)hexanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C18H33N5O5 (399.2481568)


   

Gly Lys Val Pro

(2S)-1-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C18H33N5O5 (399.2481568)


   

Gly Leu Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-methylpentanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6 (399.2117734)


   

Gly Leu Pro Asn

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C17H29N5O6 (399.2117734)


   

Gly Asn Ile Pro

(2S)-1-[(2S,3S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6 (399.2117734)


   

Gly Asn Leu Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6 (399.2117734)


   

Gly Asn Pro Ile

(2S,3S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C17H29N5O6 (399.2117734)


   

Gly Asn Pro Leu

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C17H29N5O6 (399.2117734)


   

Gly Pro Ala Arg

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}propanamido]-5-carbamimidamidopentanoic acid

C16H29N7O5 (399.22300640000003)


   

Gly Pro Ile Asn

(2S)-2-[(2S,3S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-methylpentanamido]-3-carbamoylpropanoic acid

C17H29N5O6 (399.2117734)


   

Gly Pro Lys Val

(2S)-2-[(2S)-6-amino-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}hexanamido]-3-methylbutanoic acid

C18H33N5O5 (399.2481568)


   

Gly Pro Leu Asn

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-4-methylpentanamido]-3-carbamoylpropanoic acid

C17H29N5O6 (399.2117734)


   

Gly Pro Asn Ile

(2S,3S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-3-methylpentanoic acid

C17H29N5O6 (399.2117734)


   

Gly Pro Asn Leu

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-4-methylpentanoic acid

C17H29N5O6 (399.2117734)


   

Gly Pro Gln Val

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]-3-methylbutanoic acid

C17H29N5O6 (399.2117734)


   

Gly Pro Arg Ala

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-5-carbamimidamidopentanamido]propanoic acid

C16H29N7O5 (399.22300640000003)


   

Gly Pro Val Lys

(2S)-6-amino-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-methylbutanamido]hexanoic acid

C18H33N5O5 (399.2481568)


   

Gly Pro Val Gln

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-methylbutanamido]-4-carbamoylbutanoic acid

C17H29N5O6 (399.2117734)


   

Gly Gln Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C17H29N5O6 (399.2117734)


   

Gly Gln Val Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6 (399.2117734)


   

Gly Arg Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]propanoyl]pyrrolidine-2-carboxylic acid

C16H29N7O5 (399.22300640000003)


   

Gly Arg Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C16H29N7O5 (399.22300640000003)


   

Gly Val Lys Pro

(2S)-1-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]hexanoyl]pyrrolidine-2-carboxylic acid

C18H33N5O5 (399.2481568)


   

Gly Val Pro Lys

(2S)-6-amino-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-methylbutanoyl]pyrrolidin-2-yl]formamido}hexanoic acid

C18H33N5O5 (399.2481568)


   

Gly Val Pro Gln

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C17H29N5O6 (399.2117734)


   

Gly Val Gln Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6 (399.2117734)


   
   

Ile Gly Asn Pro

(2S)-1-[(2S)-2-{2-[(2S,3S)-2-amino-3-methylpentanamido]acetamido}-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6 (399.2117734)


   

Ile Gly Pro Asn

(2S)-2-{[(2S)-1-{2-[(2S,3S)-2-amino-3-methylpentanamido]acetyl}pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C17H29N5O6 (399.2117734)


   

Ile Asn Gly Pro

(2S)-1-{2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-carbamoylpropanamido]acetyl}pyrrolidine-2-carboxylic acid

C17H29N5O6 (399.2117734)


   

Ile Asn Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}acetic acid

C17H29N5O6 (399.2117734)


   

Ile Pro Gly Asn

(2S)-2-(2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-carbamoylpropanoic acid

C17H29N5O6 (399.2117734)


   

Ile Pro Asn Gly

2-[(2S)-2-{[(2S)-1-[(2S,3S)-2-amino-3-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]acetic acid

C17H29N5O6 (399.2117734)


   

Lys Gly Pro Val

(2S)-2-{[(2S)-1-{2-[(2S)-2,6-diaminohexanamido]acetyl}pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C18H33N5O5 (399.2481568)


   

Lys Gly Val Pro

(2S)-1-[(2S)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C18H33N5O5 (399.2481568)


   

Lys Pro Gly Val

(2S)-2-(2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-methylbutanoic acid

C18H33N5O5 (399.2481568)


   

Lys Pro Val Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]acetic acid

C18H33N5O5 (399.2481568)


   

Lys Val Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]acetyl}pyrrolidine-2-carboxylic acid

C18H33N5O5 (399.2481568)


   

Lys Val Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}acetic acid

C18H33N5O5 (399.2481568)


   

Leu Gly Asn Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-4-methylpentanamido]acetamido}-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6 (399.2117734)


   

Leu Gly Pro Asn

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-4-methylpentanamido]acetyl}pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C17H29N5O6 (399.2117734)


   

Leu Asn Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-carbamoylpropanamido]acetyl}pyrrolidine-2-carboxylic acid

C17H29N5O6 (399.2117734)


   

Leu Asn Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}acetic acid

C17H29N5O6 (399.2117734)


   

Leu Pro Gly Asn

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-carbamoylpropanoic acid

C17H29N5O6 (399.2117734)


   

Leu Pro Asn Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-methylpentanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]acetic acid

C17H29N5O6 (399.2117734)


   

Asn Ala Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C17H29N5O6 (399.2117734)


   

Asn Ala Val Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6 (399.2117734)


   

Asn Gly Ile Pro

(2S)-1-[(2S,3S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-methylpentanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6 (399.2117734)


   

Asn Gly Leu Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-4-methylpentanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6 (399.2117734)


   

Asn Gly Pro Ile

(2S,3S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetyl}pyrrolidin-2-yl]formamido}-3-methylpentanoic acid

C17H29N5O6 (399.2117734)


   

Asn Gly Pro Leu

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetyl}pyrrolidin-2-yl]formamido}-4-methylpentanoic acid

C17H29N5O6 (399.2117734)


   

Asn Ile Gly Pro

(2S)-1-{2-[(2S,3S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylpentanamido]acetyl}pyrrolidine-2-carboxylic acid

C17H29N5O6 (399.2117734)


   

Asn Ile Pro Gly

2-{[(2S)-1-[(2S,3S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylpentanoyl]pyrrolidin-2-yl]formamido}acetic acid

C17H29N5O6 (399.2117734)


   

Asn Leu Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-methylpentanamido]acetyl}pyrrolidine-2-carboxylic acid

C17H29N5O6 (399.2117734)


   

Asn Leu Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-methylpentanoyl]pyrrolidin-2-yl]formamido}acetic acid

C17H29N5O6 (399.2117734)


   

Asn Pro Ala Val

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}propanamido]-3-methylbutanoic acid

C17H29N5O6 (399.2117734)


   

Asn Pro Gly Ile

(2S,3S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-methylpentanoic acid

C17H29N5O6 (399.2117734)


   

Asn Pro Gly Leu

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}acetamido)-4-methylpentanoic acid

C17H29N5O6 (399.2117734)


   

Asn Pro Ile Gly

2-[(2S,3S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-methylpentanamido]acetic acid

C17H29N5O6 (399.2117734)


   

Asn Pro Leu Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-4-methylpentanamido]acetic acid

C17H29N5O6 (399.2117734)


   

Asn Pro Val Ala

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]propanoic acid

C17H29N5O6 (399.2117734)


   
   

Asn Val Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylbutanamido]propanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6 (399.2117734)


   

Asn Val Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C17H29N5O6 (399.2117734)


   

Pro Ala Gly Arg

(2S)-5-carbamimidamido-2-{2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}pentanoic acid

C16H29N7O5 (399.22300640000003)


   

Pro Ala Asn Val

(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]-3-methylbutanoic acid

C17H29N5O6 (399.2117734)


   

Pro Ala Arg Gly

2-[(2S)-5-carbamimidamido-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]pentanamido]acetic acid

C16H29N7O5 (399.22300640000003)


   

Pro Ala Val Asn

(2S)-3-carbamoyl-2-[(2S)-3-methyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanamido]propanoic acid

C17H29N5O6 (399.2117734)


   

Pro Gly Ala Arg

(2S)-5-carbamimidamido-2-[(2S)-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]pentanoic acid

C16H29N7O5 (399.22300640000003)


   

Pro Gly Ile Asn

(2S)-3-carbamoyl-2-[(2S,3S)-3-methyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}pentanamido]propanoic acid

C17H29N5O6 (399.2117734)


   

Pro Gly Lys Val

(2S)-2-[(2S)-6-amino-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}hexanamido]-3-methylbutanoic acid

C18H33N5O5 (399.2481568)


   

Pro Gly Leu Asn

(2S)-3-carbamoyl-2-[(2S)-4-methyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}pentanamido]propanoic acid

C17H29N5O6 (399.2117734)


   

Pro Gly Asn Ile

(2S,3S)-2-[(2S)-3-carbamoyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]-3-methylpentanoic acid

C17H29N5O6 (399.2117734)


   

Pro Gly Asn Leu

(2S)-2-[(2S)-3-carbamoyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]-4-methylpentanoic acid

C17H29N5O6 (399.2117734)


   

Pro Gly Gln Val

(2S)-2-[(2S)-4-carbamoyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}butanamido]-3-methylbutanoic acid

C17H29N5O6 (399.2117734)


   

Pro Gly Arg Ala

(2S)-2-[(2S)-5-carbamimidamido-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}pentanamido]propanoic acid

C16H29N7O5 (399.22300640000003)


   

Pro Gly Val Lys

(2S)-6-amino-2-[(2S)-3-methyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}butanamido]hexanoic acid

C18H33N5O5 (399.2481568)


   

Pro Gly Val Gln

(2S)-4-carbamoyl-2-[(2S)-3-methyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}butanamido]butanoic acid

C17H29N5O6 (399.2117734)


   

Pro Ile Gly Asn

(2S)-3-carbamoyl-2-{2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]acetamido}propanoic acid

C17H29N5O6 (399.2117734)


   

Pro Ile Asn Gly

2-[(2S)-3-carbamoyl-2-[(2S,3S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanamido]acetic acid

C17H29N5O6 (399.2117734)


   

Pro Lys Gly Val

(2S)-2-{2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]acetamido}-3-methylbutanoic acid

C18H33N5O5 (399.2481568)


   

Pro Lys Val Gly

2-[(2S)-2-[(2S)-6-amino-2-[(2S)-pyrrolidin-2-ylformamido]hexanamido]-3-methylbutanamido]acetic acid

C18H33N5O5 (399.2481568)


   

Pro Leu Gly Asn

(2S)-3-carbamoyl-2-{2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]acetamido}propanoic acid

C17H29N5O6 (399.2117734)


   

Pro Leu Asn Gly

2-[(2S)-3-carbamoyl-2-[(2S)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanamido]acetic acid

C17H29N5O6 (399.2117734)


   

Pro Asn Ala Val

(2S)-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]-3-methylbutanoic acid

C17H29N5O6 (399.2117734)


   

Pro Asn Gly Ile

(2S,3S)-2-{2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}-3-methylpentanoic acid

C17H29N5O6 (399.2117734)


   

Pro Asn Gly Leu

(2S)-2-{2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}-4-methylpentanoic acid

C17H29N5O6 (399.2117734)


   

Pro Asn Ile Gly

2-[(2S,3S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-methylpentanamido]acetic acid

C17H29N5O6 (399.2117734)


   

Pro Asn Leu Gly

2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-4-methylpentanamido]acetic acid

C17H29N5O6 (399.2117734)


   

Pro Asn Val Ala

(2S)-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-methylbutanamido]propanoic acid

C17H29N5O6 (399.2117734)


   

Pro Gln Gly Val

(2S)-2-{2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]acetamido}-3-methylbutanoic acid

C17H29N5O6 (399.2117734)


   

Pro Gln Val Gly

2-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-methylbutanamido]acetic acid

C17H29N5O6 (399.2117734)


   

Pro Arg Ala Gly

2-[(2S)-2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]propanamido]acetic acid

C16H29N7O5 (399.22300640000003)


   

Pro Arg Gly Ala

(2S)-2-{2-[(2S)-5-carbamimidamido-2-[(2S)-pyrrolidin-2-ylformamido]pentanamido]acetamido}propanoic acid

C16H29N7O5 (399.22300640000003)


   

Pro Val Ala Asn

(2S)-3-carbamoyl-2-[(2S)-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]propanoic acid

C17H29N5O6 (399.2117734)


   

Pro Val Gly Lys

(2S)-6-amino-2-{2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]acetamido}hexanoic acid

C18H33N5O5 (399.2481568)


   

Pro Val Gly Gln

(2S)-4-carbamoyl-2-{2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]acetamido}butanoic acid

C17H29N5O6 (399.2117734)


   

Pro Val Lys Gly

2-[(2S)-6-amino-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]hexanamido]acetic acid

C18H33N5O5 (399.2481568)


   

Pro Val Asn Ala

(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]propanoic acid

C17H29N5O6 (399.2117734)


   

Pro Val Gln Gly

2-[(2S)-4-carbamoyl-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]butanamido]acetic acid

C17H29N5O6 (399.2117734)


   
   

Gln Gly Pro Val

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetyl}pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C17H29N5O6 (399.2117734)


   

Gln Gly Val Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6 (399.2117734)


   

Gln Pro Gly Val

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-methylbutanoic acid

C17H29N5O6 (399.2117734)


   

Gln Pro Val Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]acetic acid

C17H29N5O6 (399.2117734)


   
   

Gln Val Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-methylbutanamido]acetyl}pyrrolidine-2-carboxylic acid

C17H29N5O6 (399.2117734)


   

Gln Val Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}acetic acid

C17H29N5O6 (399.2117734)


   

Arg Ala Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanamido]acetyl}pyrrolidine-2-carboxylic acid

C16H29N7O5 (399.22300640000003)


   

Arg Ala Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanoyl]pyrrolidin-2-yl]formamido}acetic acid

C16H29N7O5 (399.22300640000003)


   

Arg Gly Ala Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}propanoyl]pyrrolidine-2-carboxylic acid

C16H29N7O5 (399.22300640000003)


   

Arg Gly Pro Ala

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetyl}pyrrolidin-2-yl]formamido}propanoic acid

C16H29N7O5 (399.22300640000003)


   

Arg Pro Ala Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}propanamido]acetic acid

C16H29N7O5 (399.22300640000003)


   

Arg Pro Gly Ala

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-5-carbamimidamidopentanoyl]pyrrolidin-2-yl]formamido}acetamido)propanoic acid

C16H29N7O5 (399.22300640000003)


   
   
   

Val Ala Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]propanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6 (399.2117734)


   

Val Ala Pro Asn

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]propanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C17H29N5O6 (399.2117734)


   

Val Gly Lys Pro

(2S)-1-[(2S)-6-amino-2-{2-[(2S)-2-amino-3-methylbutanamido]acetamido}hexanoyl]pyrrolidine-2-carboxylic acid

C18H33N5O5 (399.2481568)


   

Val Gly Pro Lys

(2S)-6-amino-2-{[(2S)-1-{2-[(2S)-2-amino-3-methylbutanamido]acetyl}pyrrolidin-2-yl]formamido}hexanoic acid

C18H33N5O5 (399.2481568)


   

Val Gly Pro Gln

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-methylbutanamido]acetyl}pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C17H29N5O6 (399.2117734)


   

Val Gly Gln Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-methylbutanamido]acetamido}-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6 (399.2117734)


   

Val Lys Gly Pro

(2S)-1-{2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]acetyl}pyrrolidine-2-carboxylic acid

C18H33N5O5 (399.2481568)


   

Val Lys Pro Gly

2-{[(2S)-1-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanoyl]pyrrolidin-2-yl]formamido}acetic acid

C18H33N5O5 (399.2481568)


   

Val Asn Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-carbamoylpropanamido]propanoyl]pyrrolidine-2-carboxylic acid

C17H29N5O6 (399.2117734)


   

Val Asn Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C17H29N5O6 (399.2117734)


   

Val Pro Ala Asn

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}propanamido]-3-carbamoylpropanoic acid

C17H29N5O6 (399.2117734)


   

Val Pro Gly Lys

(2S)-6-amino-2-(2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}acetamido)hexanoic acid

C18H33N5O5 (399.2481568)


   

Val Pro Gly Gln

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}acetamido)-4-carbamoylbutanoic acid

C17H29N5O6 (399.2117734)


   

Val Pro Lys Gly

2-[(2S)-6-amino-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}hexanamido]acetic acid

C18H33N5O5 (399.2481568)


   

Val Pro Asn Ala

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]propanoic acid

C17H29N5O6 (399.2117734)


   

Val Pro Gln Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]acetic acid

C17H29N5O6 (399.2117734)


   

Val Gln Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-carbamoylbutanamido]acetyl}pyrrolidine-2-carboxylic acid

C17H29N5O6 (399.2117734)


   

Val Gln Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}acetic acid

C17H29N5O6 (399.2117734)


   

AAPAA

Ala Ala Pro Ala Ala

C17H29N5O6 (399.2117734)


   

CAR 14:2;O2

3-{[(5Z)-13-carboxytridec-5-enoyl]oxy}-4-(trimethylazaniumyl)butanoate

C21H37NO6 (399.26207420000003)


   

Spiramine B

Spiramine D acetate

C24H33NO4 (399.2409458000001)


   

Benzenemethanaminium,N-dodecyl-N,N-bis(2-hydroxyethyl)-, chloride (1:1)

Benzenemethanaminium,N-dodecyl-N,N-bis(2-hydroxyethyl)-, chloride (1:1)

C23H42ClNO2 (399.29039020000005)


   

1-[(E)-(3-methoxyphenyl)methylideneamino]oxy-3-[4-(2-methoxyphenyl)piperazin-1-yl]propan-2-ol

1-[(E)-(3-methoxyphenyl)methylideneamino]oxy-3-[4-(2-methoxyphenyl)piperazin-1-yl]propan-2-ol

C22H29N3O4 (399.21579540000005)


   

3-De(hydroxymethyl)-3-methyl Salmeterol

3-De(hydroxymethyl)-3-methyl Salmeterol

C25H37NO3 (399.27732920000005)


   

Urea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-phenyl-N-(3-pyridinylmethyl)- (9CI)

Urea, N-[2-(5,6-dimethyl-1H-benzimidazol-2-yl)ethyl]-N-phenyl-N-(3-pyridinylmethyl)- (9CI)

C24H25N5O (399.2059)


   
   

butyl 2-methylprop-2-enoate,2-(dimethylamino)ethyl 2-methylprop-2-enoate,methyl 2-methylprop-2-enoate

butyl 2-methylprop-2-enoate,2-(dimethylamino)ethyl 2-methylprop-2-enoate,methyl 2-methylprop-2-enoate

C21H37NO6 (399.26207420000003)


   

5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-(TRIISOPROPYLSILYL)-1H-INDOLE

5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1-(TRIISOPROPYLSILYL)-1H-INDOLE

C23H38BNO2Si (399.27647179999997)


   

(S)-3-(3-METHOXYPHENYL)-4-PHENYLOXAZOLIDIN-2-ONE

(S)-3-(3-METHOXYPHENYL)-4-PHENYLOXAZOLIDIN-2-ONE

C23H29NO5 (399.20456240000004)


   

Epristeride

Epristeride

C25H37NO3 (399.27732920000005)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D058891 - 5-alpha Reductase Inhibitors C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C242 - Anti-Androgen C471 - Enzyme Inhibitor > C2319 - 5 Alpha-Reductase Inhibitor C1892 - Chemopreventive Agent

   

bis(2-hydroxyethyl)ammonium tetradecyl sulphate

bis(2-hydroxyethyl)ammonium tetradecyl sulphate

C18H41NO6S (399.2654446000001)


   

1-(3,4-DICHLOROPHENYL)BUTANE-1,3-DIONE

1-(3,4-DICHLOROPHENYL)BUTANE-1,3-DIONE

C24H33NO4 (399.2409458000001)


   

(2S)-2-[[(4R,5R)-1,3-dimethyl-4,5-diphenylimidazolidin-2-ylidene]amino]-3-phenylpropan-1-ol

(2S)-2-[[(4R,5R)-1,3-dimethyl-4,5-diphenylimidazolidin-2-ylidene]amino]-3-phenylpropan-1-ol

C26H29N3O (399.2310504)


   

butyl prop-2-enoate,methyl 2-methylprop-2-enoate,2-methylprop-2-enamide,2-methylprop-2-enoic acid

butyl prop-2-enoate,methyl 2-methylprop-2-enoate,2-methylprop-2-enamide,2-methylprop-2-enoic acid

C20H33NO7 (399.22569080000005)


   

carboxymethylcellulose calcium (1.5 g) (as)

carboxymethylcellulose calcium (1.5 g) (as)

C23H30ClN3O (399.20772800000003)


   

sodium 2-[methyl(1-oxohexadecyl)amino]ethanesulphonate

sodium 2-[methyl(1-oxohexadecyl)amino]ethanesulphonate

C19H38NNaO4S (399.2419108000001)


   

1-(TRIISOPROPYLSILYL)-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-INDOLE

1-(TRIISOPROPYLSILYL)-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-INDOLE

C23H38BNO2Si (399.27647179999997)


   

(trans,trans)-4-Pentyl-[1,1-bicyclohexyl]-4-carboxylic acid 4-cyano-3-fluorophenyl ester

(trans,trans)-4-Pentyl-[1,1-bicyclohexyl]-4-carboxylic acid 4-cyano-3-fluorophenyl ester

C25H34FNO2 (399.2573436)


   

5-Methoxy-2,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole

5-Methoxy-2,7-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole

C21H31B2NO5 (399.23882160000005)


   

(S)-1-[(R)-2-METHOXY-1-(4-TRIFLUOROMETHYL-PHENYL)-ETHYL]-2-METHYL-4-(4-METHYL-PIPERIDIN-4-YL)-PIPERAZINE

(S)-1-[(R)-2-METHOXY-1-(4-TRIFLUOROMETHYL-PHENYL)-ETHYL]-2-METHYL-4-(4-METHYL-PIPERIDIN-4-YL)-PIPERAZINE

C21H32F3N3O (399.2497338)


   

Desvenlafaxine succinate

Desvenlafaxine succinate

C20H33NO7 (399.22569080000005)


D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D000068760 - Serotonin and Noradrenaline Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D049990 - Membrane Transport Modulators

   

Urea, N-cyclopropyl-N-(3-((1,2-dihydro-2-oxo-6-quinolinyl)oxy)propyl)-N-((1R,2R)-2-hydroxycyclohexyl)-

Urea, N-cyclopropyl-N-(3-((1,2-dihydro-2-oxo-6-quinolinyl)oxy)propyl)-N-((1R,2R)-2-hydroxycyclohexyl)-

C22H29N3O4 (399.21579540000005)


   

1-[1-(3-Aminophenyl)-3-Tert-Butyl-1h-Pyrazol-5-Yl]-3-Naphthalen-1-Ylurea

1-[1-(3-Aminophenyl)-3-Tert-Butyl-1h-Pyrazol-5-Yl]-3-Naphthalen-1-Ylurea

C24H25N5O (399.2059)


   
   

Fmk-mea

Fmk-mea

C21H26FN5O2 (399.2070428)


FMK-MEA is a potent and selective p90 Ribosomal S6 Kinase (RSK) inhibitor.

   
   

5,6-Diphenyl-N-(2-piperazin-1-ylethyl)furo[2,3-D]pyrimidin-4-amine

5,6-Diphenyl-N-(2-piperazin-1-ylethyl)furo[2,3-D]pyrimidin-4-amine

C24H25N5O (399.2059)


   

[4-(3-Aminomethyl-phenyl)-piperidin-1-YL]-(5-phenethyl-pyridin-3-YL)-methanone

[4-(3-Aminomethyl-phenyl)-piperidin-1-YL]-(5-phenethyl-pyridin-3-YL)-methanone

C26H29N3O (399.2310504)


   

N-Cycloheptylglycyl-N-(4-Carbamimidoylbenzyl)-L-Prolinamide

N-Cycloheptylglycyl-N-(4-Carbamimidoylbenzyl)-L-Prolinamide

C22H33N5O2 (399.26341180000003)


   

3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide

3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide

C24H25N5O (399.2059)


   

N-[2-(1-Formyl-2-methyl-propyl)-1-(4-piperidin-1-YL-but-2-enoyl)-pyrrolidin-3-YL]-methanesulfonamide

N-[2-(1-Formyl-2-methyl-propyl)-1-(4-piperidin-1-YL-but-2-enoyl)-pyrrolidin-3-YL]-methanesulfonamide

C19H33N3O4S (399.2191658000001)


   

3-[(1,2,4a,5-Tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl)methyl]-4-hydroxy-5-(2-methylpropylamino)cyclohexa-3,5-diene-1,2-dione

3-[(1,2,4a,5-Tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl)methyl]-4-hydroxy-5-(2-methylpropylamino)cyclohexa-3,5-diene-1,2-dione

C25H37NO3 (399.27732920000005)


   

Deacetoxyvindolinium cation

Deacetoxyvindolinium cation

C23H31N2O4+ (399.2283706)


   

5-Hydroxy-4,4,6-tris(3-methylbut-2-en-1-yl)-2-(2-methylpropanoyl)-3-oxocyclohexa-1,5-dien-1-olate

5-Hydroxy-4,4,6-tris(3-methylbut-2-en-1-yl)-2-(2-methylpropanoyl)-3-oxocyclohexa-1,5-dien-1-olate

C25H35O4- (399.25352100000003)


   

N-(2-amino-3-phenylpropanoyl)-1-[1-cyano-4-(diaminomethylideneamino)butyl]pyrrolidine-2-carboxamide

N-(2-amino-3-phenylpropanoyl)-1-[1-cyano-4-(diaminomethylideneamino)butyl]pyrrolidine-2-carboxamide

C20H29N7O2 (399.2382614)


   
   
   

(7Z)-Tetradec-7-enedioylcarnitine

(7Z)-Tetradec-7-enedioylcarnitine

C21H37NO6 (399.26207420000003)


   

(2E)-Tetradec-2-enedioylcarnitine

(2E)-Tetradec-2-enedioylcarnitine

C21H37NO6 (399.26207420000003)


   

(4Z)-Tetradec-4-enedioylcarnitine

(4Z)-Tetradec-4-enedioylcarnitine

C21H37NO6 (399.26207420000003)


   

(5E)-Tetradec-5-enedioylcarnitine

(5E)-Tetradec-5-enedioylcarnitine

C21H37NO6 (399.26207420000003)


   

(4R,5S,6R,7R,9E,11Z)-13-amino-7-hydroxy-4,6-dimethyl-13-oxotrideca-9,11-dien-5-yl (2E)-3-phenylprop-2-enoate

(4R,5S,6R,7R,9E,11Z)-13-amino-7-hydroxy-4,6-dimethyl-13-oxotrideca-9,11-dien-5-yl (2E)-3-phenylprop-2-enoate

C24H33NO4 (399.2409458000001)


   

N-(2-furanylmethyl)-2-[4-(phenylmethyl)-1-piperazinyl]-4-quinazolinamine

N-(2-furanylmethyl)-2-[4-(phenylmethyl)-1-piperazinyl]-4-quinazolinamine

C24H25N5O (399.2059)


   

Aspernidine A

Aspernidine A

C24H33NO4 (399.2409458000001)


A member of the class of isoindoles that is isoindolin-1-one which is substituted at positions 4, 5 and 6 by hydroxy, triprenyloxy and methoxy groups, respectively. The alkaloid was isolated from the model fungus Aspegillus nidulans.

   

1-Butyl-3-[2-(4-ethyl-1-piperazinyl)-4-methyl-6-quinolinyl]-1-methylthiourea

1-Butyl-3-[2-(4-ethyl-1-piperazinyl)-4-methyl-6-quinolinyl]-1-methylthiourea

C22H33N5S (399.24565380000007)


   
   
   
   

(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C22H29N3O4 (399.21579540000005)


   

2-(dimethylamino)-N-ethyl-N-[[(2R,3S,4R)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]acetamide

2-(dimethylamino)-N-ethyl-N-[[(2R,3S,4R)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]acetamide

C23H30FN3O2 (399.2321932)


   

1-[[(2S,3R,4R)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-3-propylurea

1-[[(2S,3R,4R)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-3-propylurea

C23H33N3O3 (399.2521788)


   

(2S,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-2-(hydroxymethyl)-4-[(propan-2-ylamino)methyl]-N-propyl-1-azetidinecarboxamide

(2S,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-2-(hydroxymethyl)-4-[(propan-2-ylamino)methyl]-N-propyl-1-azetidinecarboxamide

C24H37N3O2 (399.2885622)


   

N-[[(2S,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-(dimethylamino)-N-propan-2-ylacetamide

N-[[(2S,3R,4S)-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-(dimethylamino)-N-propan-2-ylacetamide

C24H37N3O2 (399.2885622)


   

1-[[(2S,3R,4S)-1-(cyclopentylmethyl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-3-propan-2-ylurea

1-[[(2S,3R,4S)-1-(cyclopentylmethyl)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-3-propan-2-ylurea

C24H37N3O2 (399.2885622)


   

2-cyclohexyl-1-[(E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]-2,3-dihydropyridin-6-one

2-cyclohexyl-1-[(E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]-2,3-dihydropyridin-6-one

C23H29NO5 (399.20456240000004)


   

(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C22H29N3O4 (399.21579540000005)


   

(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C22H29N3O4 (399.21579540000005)


   

2-(dimethylamino)-N-ethyl-N-[[(2S,3R,4S)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]acetamide

2-(dimethylamino)-N-ethyl-N-[[(2S,3R,4S)-3-[4-(3-fluorophenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]acetamide

C23H30FN3O2 (399.2321932)


   

N-[[(2S,3S,4R)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-(dimethylamino)acetamide

N-[[(2S,3S,4R)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-(dimethylamino)acetamide

C23H33N3O3 (399.2521788)


   

N-[[(2R,3R,4S)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-(dimethylamino)acetamide

N-[[(2R,3R,4S)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-(dimethylamino)acetamide

C23H33N3O3 (399.2521788)


   

1-[[(2S,3S,4R)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-3-propylurea

1-[[(2S,3S,4R)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-3-propylurea

C23H33N3O3 (399.2521788)


   

1-[[(2R,3R,4S)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-3-propylurea

1-[[(2R,3R,4S)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-3-propylurea

C23H33N3O3 (399.2521788)


   

(2R,3S)-6-[cyclohexyl(oxo)methyl]-2-(hydroxymethyl)-3-phenyl-N-propyl-1,6-diazaspiro[3.3]heptane-1-carboxamide

(2R,3S)-6-[cyclohexyl(oxo)methyl]-2-(hydroxymethyl)-3-phenyl-N-propyl-1,6-diazaspiro[3.3]heptane-1-carboxamide

C23H33N3O3 (399.2521788)


   

(E,4S)-4-[[(2S)-2-[[(2S)-2-(diaminomethylideneazaniumyl)-3-hydroxypropanoyl]amino]-3-methylbutanoyl]-methylamino]-2,5-dimethylhex-2-enoate

(E,4S)-4-[[(2S)-2-[[(2S)-2-(diaminomethylideneazaniumyl)-3-hydroxypropanoyl]amino]-3-methylbutanoyl]-methylamino]-2,5-dimethylhex-2-enoate

C18H33N5O5 (399.2481568)


   

(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C22H29N3O4 (399.21579540000005)


   

(2S,3R)-8-(2-cyclohexylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2S,3R)-8-(2-cyclohexylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C23H33N3O3 (399.2521788)


   

(2R,3S)-8-(2-cyclohexylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2R,3S)-8-(2-cyclohexylethynyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C23H33N3O3 (399.2521788)


   

(2R,3S)-8-(2-cyclohexylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2R,3S)-8-(2-cyclohexylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C23H33N3O3 (399.2521788)


   

(2S,3R)-8-(2-cyclohexylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2S,3R)-8-(2-cyclohexylethynyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C23H33N3O3 (399.2521788)


   

(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C22H29N3O4 (399.21579540000005)


   

(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C22H29N3O4 (399.21579540000005)


   

(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C22H29N3O4 (399.21579540000005)


   

(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-8-(4-methoxyphenyl)-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C22H29N3O4 (399.21579540000005)


   

N-[[(2S,3R,4R)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-(dimethylamino)acetamide

N-[[(2S,3R,4R)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-(dimethylamino)acetamide

C23H33N3O3 (399.2521788)


   

N-[[(2R,3S,4S)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-(dimethylamino)acetamide

N-[[(2R,3S,4S)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-2-(dimethylamino)acetamide

C23H33N3O3 (399.2521788)


   

1-[[(2R,3S,4S)-1-acetyl-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-3-cyclopentyl-1-methylurea

1-[[(2R,3S,4S)-1-acetyl-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]azetidin-2-yl]methyl]-3-cyclopentyl-1-methylurea

C23H33N3O3 (399.2521788)


   

1-[[(2R,3S,4S)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-3-propylurea

1-[[(2R,3S,4S)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-3-propylurea

C23H33N3O3 (399.2521788)


   

1-[[(2S,3R,4S)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-3-propylurea

1-[[(2S,3R,4S)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-3-propylurea

C23H33N3O3 (399.2521788)


   

(2S,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-2-(hydroxymethyl)-N-propan-2-yl-4-[(propan-2-ylamino)methyl]-1-azetidinecarboxamide

(2S,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-2-(hydroxymethyl)-N-propan-2-yl-4-[(propan-2-ylamino)methyl]-1-azetidinecarboxamide

C24H37N3O2 (399.2885622)


   

(2R,3S,4S)-3-[4-(1-cyclohexenyl)phenyl]-2-(hydroxymethyl)-N-propan-2-yl-4-[(propan-2-ylamino)methyl]-1-azetidinecarboxamide

(2R,3S,4S)-3-[4-(1-cyclohexenyl)phenyl]-2-(hydroxymethyl)-N-propan-2-yl-4-[(propan-2-ylamino)methyl]-1-azetidinecarboxamide

C24H37N3O2 (399.2885622)


   

(2S,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-2-(hydroxymethyl)-4-[(propan-2-ylamino)methyl]-N-propyl-1-azetidinecarboxamide

(2S,3R,4R)-3-[4-(1-cyclohexenyl)phenyl]-2-(hydroxymethyl)-4-[(propan-2-ylamino)methyl]-N-propyl-1-azetidinecarboxamide

C24H37N3O2 (399.2885622)


   

(2R,3R)-6-[cyclohexyl(oxo)methyl]-2-(hydroxymethyl)-3-phenyl-N-propyl-1,6-diazaspiro[3.3]heptane-1-carboxamide

(2R,3R)-6-[cyclohexyl(oxo)methyl]-2-(hydroxymethyl)-3-phenyl-N-propyl-1,6-diazaspiro[3.3]heptane-1-carboxamide

C23H33N3O3 (399.2521788)


   

(2S,3R)-6-[cyclohexyl(oxo)methyl]-2-(hydroxymethyl)-3-phenyl-N-propyl-1,6-diazaspiro[3.3]heptane-1-carboxamide

(2S,3R)-6-[cyclohexyl(oxo)methyl]-2-(hydroxymethyl)-3-phenyl-N-propyl-1,6-diazaspiro[3.3]heptane-1-carboxamide

C23H33N3O3 (399.2521788)


   

(2S,3S)-6-[cyclohexyl(oxo)methyl]-2-(hydroxymethyl)-3-phenyl-N-propyl-1,6-diazaspiro[3.3]heptane-1-carboxamide

(2S,3S)-6-[cyclohexyl(oxo)methyl]-2-(hydroxymethyl)-3-phenyl-N-propyl-1,6-diazaspiro[3.3]heptane-1-carboxamide

C23H33N3O3 (399.2521788)


   
   

(2E)-16-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]hexadec-2-enoate

(2E)-16-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]hexadec-2-enoate

C22H39O6- (399.2746494)


   

(2S,3S,3aR,9bR)-1-(2-cyclopropylacetyl)-N-ethyl-3-(hydroxymethyl)-6-oxo-7-[(E)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

(2S,3S,3aR,9bR)-1-(2-cyclopropylacetyl)-N-ethyl-3-(hydroxymethyl)-6-oxo-7-[(E)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C22H29N3O4 (399.21579540000005)


   

(2R,3R,3aS,9bS)-1-(2-cyclopropylacetyl)-N-ethyl-3-(hydroxymethyl)-6-oxo-7-[(E)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

(2R,3R,3aS,9bS)-1-(2-cyclopropylacetyl)-N-ethyl-3-(hydroxymethyl)-6-oxo-7-[(E)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C22H29N3O4 (399.21579540000005)


   

(E,15R)-15-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxyhexadec-2-enoate

(E,15R)-15-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxyhexadec-2-enoate

C22H39O6- (399.2746494)


   

methyl (E)-2-[(3R,4R,6R,7S,8aR)-6-ethyl-4-methyl-2-oxospiro[1H-indole-3,1-3,5,6,7,8,8a-hexahydro-2H-indolizin-4-ium]-7-yl]-3-methoxyprop-2-enoate

methyl (E)-2-[(3R,4R,6R,7S,8aR)-6-ethyl-4-methyl-2-oxospiro[1H-indole-3,1-3,5,6,7,8,8a-hexahydro-2H-indolizin-4-ium]-7-yl]-3-methoxyprop-2-enoate

C23H31N2O4+ (399.2283706)


   
   

quinacrine

Quinacrine Dihydrochloride Dihydrate

C23H30ClN3O (399.20772800000003)


P - Antiparasitic products, insecticides and repellents > P01 - Antiprotozoals > P01A - Agents against amoebiasis and other protozoal diseases D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors

   

dorsomorphin

dorsomorphin

C24H25N5O (399.2059)


D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors Dorsomorphin (Compound C) is a selective and ATP-competitive AMPK inhibitor (Ki=109 nM in the absence of AMP). Dorsomorphin (BML-275) selectively inhibits BMP type I receptors ALK2, ALK3, and ALK6. Dorsomorphin can reverse autophagy activation and anti-inflammatory effect of Urolithin A (HY-100599)[1][2].

   

deacetoxyvindolinium(1+)

deacetoxyvindolinium(1+)

C23H31N2O4 (399.2283706)


The conjugate acid of deacetoxyvindoline arising from protonation of the tertiary amino group; major species at pH 7.3.

   

colupulone(1-)

colupulone(1-)

C25H35O4 (399.25352100000003)


A beta-bitter acid(1-) that is the conjugate base of colupulone, obtained by deprotonation of one of the enolic hydroxy groups. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

   

(5Z)-13-carboxytridec-5-enoylcarnitine

(5Z)-13-carboxytridec-5-enoylcarnitine

C21H37NO6 (399.26207420000003)


An O-acylcarnitine having (5Z)-13-carboxytridec-5-enoyl as the acyl substituent.

   

YM-47522

YM-47522

C24H33NO4 (399.2409458000001)


A cinnamate ester obtained by the formal condensation of the carboxy group of trans-cinnamic acid with the 9-hydroxy group of 7,9-dihydroxy-8,10-dimethyltrideca-2,4-dienamide (the 4R,5S,6R,7R,9E,11Z stereoisomer). It is obtained from the fermentation broth of Bacillus sp.YL-03709B and exhibits antifungal activity.

   

ascr#27(1-)

ascr#27(1-)

C22H39O6 (399.2746494)


Conjugate base of ascr#27

   

oscr#27(1-)

oscr#27(1-)

C22H39O6 (399.2746494)


A hydroxy fatty acid ascaroside anion that is the conjugate base of oscr#27, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   
   

NA-Ala 22:6(4Z,7Z,10Z,13Z,16Z,19Z)

NA-Ala 22:6(4Z,7Z,10Z,13Z,16Z,19Z)

C25H37NO3 (399.27732920000005)


   
   
   
   
   
   
   
   
   
   

(±)-J-113397

(±)-J-113397

C24H37N3O2 (399.2885622)


(±)-J-113397 is a potent and selective non-peptidyl ORL1 receptor antagonist with a Ki of 1.8 nM for cloned human ORL1. J-113397 inhibited nociceptin/orphanin FQ-stimulated GTPγS binding to CHO cells expressing ORL1 with an IC50 value of 5.3 nM. J-113397 can be used for researching the physiological roles of nociceptin/orphanin FQ[1].

   

(2z,4e,7s,8s,9r,10s)-7-hydroxy-8,10-dimethyl-9-{[(2e)-3-phenylprop-2-enoyl]oxy}trideca-2,4-dienimidic acid

(2z,4e,7s,8s,9r,10s)-7-hydroxy-8,10-dimethyl-9-{[(2e)-3-phenylprop-2-enoyl]oxy}trideca-2,4-dienimidic acid

C24H33NO4 (399.2409458000001)


   

methyl 18-hydroxy-11-(2-hydroxyethyl)-2,15-dimethyl-9-oxo-4-azapentacyclo[11.4.1.0⁴,¹⁶.0⁶,¹⁵.0¹⁰,¹⁴]octadeca-10(14),11,13(18)-triene-12-carboxylate

methyl 18-hydroxy-11-(2-hydroxyethyl)-2,15-dimethyl-9-oxo-4-azapentacyclo[11.4.1.0⁴,¹⁶.0⁶,¹⁵.0¹⁰,¹⁴]octadeca-10(14),11,13(18)-triene-12-carboxylate

C23H29NO5 (399.20456240000004)


   

(1r,2r,5s,7r,8r,13s,18s,21s)-12-methyl-4-methylidene-14,19-dioxa-17-azaheptacyclo[10.7.2.2²,⁵.0²,⁷.0⁸,¹⁸.0⁸,²¹.0¹³,¹⁷]tricosan-3-yl acetate

(1r,2r,5s,7r,8r,13s,18s,21s)-12-methyl-4-methylidene-14,19-dioxa-17-azaheptacyclo[10.7.2.2²,⁵.0²,⁷.0⁸,¹⁸.0⁸,²¹.0¹³,¹⁷]tricosan-3-yl acetate

C24H33NO4 (399.2409458000001)


   

3-{[(1r,2s,4ar,8as)-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]methyl}-2-hydroxy-5-[(2-methylpropyl)amino]cyclohexa-2,5-diene-1,4-dione

3-{[(1r,2s,4ar,8as)-1,2,4a-trimethyl-5-methylidene-hexahydro-2h-naphthalen-1-yl]methyl}-2-hydroxy-5-[(2-methylpropyl)amino]cyclohexa-2,5-diene-1,4-dione

C25H37NO3 (399.27732920000005)


   

(5s)-3-[(1r,2s,4ar,6r,8ar)-1,6-dimethyl-2-[(1e,3e)-penta-1,3-dien-1-yl]-4a,5,6,7,8,8a-hexahydro-2h-naphthalene-1-carbonyl]-5-[(1s)-1-hydroxyethyl]-5h-pyrrole-2,4-diol

(5s)-3-[(1r,2s,4ar,6r,8ar)-1,6-dimethyl-2-[(1e,3e)-penta-1,3-dien-1-yl]-4a,5,6,7,8,8a-hexahydro-2h-naphthalene-1-carbonyl]-5-[(1s)-1-hydroxyethyl]-5h-pyrrole-2,4-diol

C24H33NO4 (399.2409458000001)


   

11-ethyl-16-hydroxy-5-methyl-18-methylidene-9-oxa-11-azaheptacyclo[15.2.1.0¹,¹⁴.0²,¹².0⁴,¹³.0⁵,¹⁰.0⁸,¹³]icosan-19-yl acetate

11-ethyl-16-hydroxy-5-methyl-18-methylidene-9-oxa-11-azaheptacyclo[15.2.1.0¹,¹⁴.0²,¹².0⁴,¹³.0⁵,¹⁰.0⁸,¹³]icosan-19-yl acetate

C24H33NO4 (399.2409458000001)


   

(2s,4s,5s,8r,10s,13r,14r,16s,17r,19r)-11-ethyl-16-hydroxy-5-methyl-18-methylidene-9-oxa-11-azaheptacyclo[15.2.1.0¹,¹⁴.0²,¹².0⁴,¹³.0⁵,¹⁰.0⁸,¹³]icosan-19-yl acetate

(2s,4s,5s,8r,10s,13r,14r,16s,17r,19r)-11-ethyl-16-hydroxy-5-methyl-18-methylidene-9-oxa-11-azaheptacyclo[15.2.1.0¹,¹⁴.0²,¹².0⁴,¹³.0⁵,¹⁰.0⁸,¹³]icosan-19-yl acetate

C24H33NO4 (399.2409458000001)


   

6-methoxy-5-[(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy]-3h-isoindole-1,4-diol

6-methoxy-5-[(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy]-3h-isoindole-1,4-diol

C24H33NO4 (399.2409458000001)


   

(1r,2r,4s,5r,8s,10r,12s,13s,14r,16r,17r,19r)-11-ethyl-16-hydroxy-5-methyl-18-methylidene-9-oxa-11-azaheptacyclo[15.2.1.0¹,¹⁴.0²,¹².0⁴,¹³.0⁵,¹⁰.0⁸,¹³]icosan-19-yl acetate

(1r,2r,4s,5r,8s,10r,12s,13s,14r,16r,17r,19r)-11-ethyl-16-hydroxy-5-methyl-18-methylidene-9-oxa-11-azaheptacyclo[15.2.1.0¹,¹⁴.0²,¹².0⁴,¹³.0⁵,¹⁰.0⁸,¹³]icosan-19-yl acetate

C24H33NO4 (399.2409458000001)


   

6-methoxy-5-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}-3h-isoindole-1,4-diol

6-methoxy-5-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}-3h-isoindole-1,4-diol

C24H33NO4 (399.2409458000001)


   

4,6,6'-trihydroxy-2',5',5',8'a-tetramethyl-3',4',4'a,6',7',8'-hexahydro-2'h,3h-spiro[furo[2,3-e]isoindole-2,1'-naphthalen]-8-one

4,6,6'-trihydroxy-2',5',5',8'a-tetramethyl-3',4',4'a,6',7',8'-hexahydro-2'h,3h-spiro[furo[2,3-e]isoindole-2,1'-naphthalen]-8-one

C23H29NO5 (399.20456240000004)